 Connection
Jason Burdick to Interleukin-10
This is a "connection" page, showing publications Jason Burdick has written about Interleukin-10.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.936 |
|
|
|
-
Chen MH, Chung JJ, Mealy JE, Zaman S, Li EC, Arisi MF, Atluri P, Burdick JA. Injectable Supramolecular Hydrogel/Microgel Composites for Therapeutic Delivery. Macromol Biosci. 2019 01; 19(1):e1800248.
Score: 0.568
-
Soranno DE, Rodell CB, Altmann C, Duplantis J, Andres-Hernando A, Burdick JA, Faubel S. Delivery of interleukin-10 via injectable hydrogels improves renal outcomes and reduces systemic inflammation following ischemic acute kidney injury in mice. Am J Physiol Renal Physiol. 2016 08 01; 311(2):F362-72.
Score: 0.119
-
Rodell CB, Rai R, Faubel S, Burdick JA, Soranno DE. Local immunotherapy via delivery of interleukin-10 and transforming growth factor ? antagonist for treatment of chronic kidney disease. J Control Release. 2015 May 28; 206:131-9.
Score: 0.111
-
Soranno DE, Lu HD, Weber HM, Rai R, Burdick JA. Immunotherapy with injectable hydrogels to treat obstructive nephropathy. J Biomed Mater Res A. 2014 Jul; 102(7):2173-80.
Score: 0.100
-
Briggs WA, Wu Q, Orgul O, Choi M, Scheel PJ, Burdick J. Lymphocyte suppression by rolipram with other immunosuppressive drugs. J Clin Pharmacol. 1999 Aug; 39(8):794-9.
Score: 0.038
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|